+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cattle Health Market by Product Type, Distribution Channel, Cattle Type, Disease Type, Route of Administration, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010758
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cattle Health Market grew from USD 7.87 billion in 2024 to USD 8.33 billion in 2025. It is expected to continue growing at a CAGR of 5.62%, reaching USD 10.92 billion by 2030.

Navigating the Evolving Terrain of Cattle Health Management

Cattle health management is experiencing a pivotal moment as industry stakeholders confront unprecedented challenges and opportunities. Advances in diagnostic technologies, along with heightened regulatory scrutiny, are reshaping the way producers, veterinarians, and suppliers approach disease prevention and therapeutic interventions. At the same time, global supply chain complexities have underscored the critical importance of resilient procurement strategies and diversified sourcing for essential pharmaceuticals and feed additives.

In this dynamic context, decision-makers require an integrated perspective that spans the latest scientific developments and market drivers. Robust vaccines, precision nutrition, and real-time monitoring tools are converging to form a new paradigm in livestock health, one that prioritizes both animal welfare and operational efficiency. As economic pressures intensify, optimizing the balance between cost containment and proactive disease management becomes essential.

This executive summary synthesizes the key trends, market shifts, and strategic imperatives shaping the cattle health landscape. By presenting data-backed insights across product categories, disease applications, and distribution channels, we aim to equip stakeholders with the clarity needed to navigate uncertainty and seize emerging growth avenues.

Emerging Forces Redefining Cattle Health Solutions

Over the past five years, the cattle health sector has been transformed by a cascade of technological breakthroughs and shifting consumer expectations. Cutting-edge rapid test kits are complementing traditional laboratory analyses to deliver on-farm diagnostics with unprecedented speed. Meanwhile, next-generation vaccines targeting bacterial, viral, and parasitic threats are driving a shift toward more precise and tailored immunization protocols.

Simultaneously, the convergence of nutritional science and microbiome research has accelerated innovation within feed additives, where enzymes, prebiotics, probiotics, vitamins, and minerals are formulated to enhance gut health and bolster immune response. The integration of digital health platforms further enables veterinarians and producers to monitor animal welfare metrics continuously, facilitating early intervention and data-driven management.

This wave of transformation extends beyond product innovation. Distribution channels are evolving as farm supplies outlets, online platforms, pharmacies, and veterinary hospitals and clinics converge to offer seamless procurement experiences. As these forces intersect, the sector must adapt its regulatory and logistical frameworks to uphold safety standards while maximizing accessibility.

Assessing the Ripple Effects of 2025 US Tariff Policies

The introduction of revised U.S. tariffs in 2025 has triggered significant reverberations across the cattle health market. Key raw materials for pharmaceuticals and vaccines, sourced from international suppliers, are now subject to higher import duties, prompting manufacturers to reassess their supply chains. In response, some leading players have pursued near-shoring strategies, relocating production facilities closer to domestic demand centers to mitigate cost pressures and reduce lead times.

At the same time, elevated tariffs on diagnostic reagents and rapid test components have encouraged research into alternative assay formats with locally available inputs. Feed additive producers have also faced margin compression, particularly for enzymes and specialty nutritional compounds that rely on global supply networks. These producers are intensifying partnerships with bioprocessing firms in the United States to develop indigenous capabilities and ensure supply continuity.

Despite the short-term headwinds, the tariff landscape is catalyzing a broader strategic realignment. Firms that proactively diversify their supplier portfolios and invest in regional manufacturing infrastructure stand to strengthen their competitive positioning. Moreover, enhanced domestic capacity can spur innovation, as collaborations between research institutions and industry stakeholders accelerate the development of next-generation therapeutics and diagnostics.

Unpacking Market Segments to Illuminate Growth Pathways

Understanding the market requires a nuanced analysis rooted in five critical segmentation frameworks. Examining product types reveals that diagnostics, ranging from laboratory testing to rapid test kits, form the backbone of early disease detection, while feed additives such as enzymes, prebiotics, probiotics, and vitamins and minerals drive preventive health. Pharmaceuticals comprised of anthelmintics, anti-inflammatories, antibiotics, and hormones and growth promoters address acute and chronic conditions, complemented by bacterial, parasitic, and viral vaccines that support herd immunity.

Distribution channels encompass traditional farm supplies outlets alongside digitally enabled online platforms, as well as pharmacies and veterinary hospitals and clinics, each offering distinct access points for end users. Cattle type segmentation differentiates beef, calves, and dairy operations, reflecting divergent health priorities and management protocols. Disease type analysis spans bacterial diseases, metabolic disorders, parasitic infections, reproductive challenges, respiratory ailments, and viral threats, underscoring the breadth of therapeutic applications.

Route of administration insights, covering inhalation, injectable, oral, and topical delivery methods, inform product development and adoption strategies. Lastly, application-based segmentation highlights growth promotion, nutritional supplementation, preventive measures, reproductive management, and therapeutic interventions, which together map the full spectrum of cattle health solutions. Integrating these segmentation lenses yields a comprehensive understanding of market dynamics and pinpoint growth opportunities.

Regional Dynamics Shaping Global Cattle Health Trends

Regional analysis reveals contrasting trends across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting unique drivers and barriers. In the Americas, robust R&D investments and expanding dairy and beef operations underpin demand for advanced diagnostics and vaccines. Conversely, regulatory modernization is a focal point in Europe, Middle East & Africa, where harmonizing standards can accelerate product approvals and cross-border trade.

Asia-Pacific is characterized by rapid herd expansion and intensifying biosecurity concerns, fueling uptake of feed additives and preventive therapeutics. In response, global and local players are forging strategic alliances to tailor offerings and navigate diverse regulatory environments. Meanwhile, evolving consumer preferences around antimicrobial stewardship are shaping product pipelines and usage protocols across all regions.

These regional dynamics underscore the importance of localized market entry strategies, adaptive distribution networks, and collaborative regulatory engagement. Firms that align their product portfolios and go-to-market models with regional priorities can capitalize on emerging growth corridors while mitigating geopolitical and logistical risks.

Strategic Moves by Industry Front-Runners

Leading companies are leveraging strategic acquisitions, joint ventures, and in-house innovation to consolidate their positions and expand capabilities. Key players are integrating diagnostics and therapeutic offerings to provide end-to-end solutions, while forging alliances with digital health providers to embed connectivity and analytics into their products.

Strategic investments in manufacturing capacity, particularly for vaccines and biologics, are enabling faster response to disease outbreaks and reducing reliance on third-party suppliers. Meanwhile, partnerships with contract research organizations and academic institutions are accelerating pipeline development across novel anthelmintics, immunomodulators, and feed additive formulations.

Competitive differentiation is increasingly driven by service models that extend beyond product delivery, encompassing remote monitoring, data analytics, and tailored advisory services. These value-added offerings not only strengthen customer engagement but also generate recurring revenue streams, cementing long-term partnerships with producers and veterinary practices.

Strategic Imperatives for Driving Future Success

To capitalize on emerging opportunities and fortify market resilience, industry leaders should adopt a multifaceted strategy. First, diversifying supply chains through regional manufacturing partnerships will mitigate tariff-related cost impacts and enhance production agility. Investing in modular facility designs can further accelerate capacity expansions in response to fluctuating demand.

Second, embracing digital health platforms will strengthen customer relationships and unlock new revenue models. Embedding real-time monitoring and predictive analytics into product offerings enables proactive disease management and supports data-driven decision-making for producers and veterinarians alike. Collaborative pilots with technology providers can refine these capabilities and demonstrate tangible value.

Third, prioritizing antimicrobial stewardship and sustainable growth promotion will align product pipelines with evolving regulatory and consumer expectations. Developing next-generation feed additives and vaccines that reduce reliance on traditional antibiotics can address public health concerns and open access to premium markets. Finally, targeted engagement with regional regulatory bodies will facilitate streamlined approval processes and ensure compliance, laying the groundwork for accelerated market entry.

Rigorous Framework Supporting Robust Market Analysis

The analysis underpinning this report relies on a rigorous four-stage approach to ensure accuracy and depth. The initial phase involves secondary research, where proprietary databases, peer-reviewed journals, regulatory filings, and industry publications are examined to map the landscape of cattle health solutions. Complementing this, expert interviews with veterinarians, producers, and regulatory specialists provide qualitative context and validate emerging trends.

In the third phase, data triangulation integrates quantitative metrics from diverse sources to reconcile discrepancies and reinforce findings. This stage leverages statistical models to assess historical trajectories and identify key inflection points, without extending into forecasting. The final phase consists of comprehensive peer reviews and editorial audits to ensure consistency, clarity, and adherence to methodological standards.

Throughout the process, stringent quality controls and ethical guidelines are maintained, guaranteeing that the insights presented are both robust and actionable. Transparency in data sourcing and analytical assumptions further enhances the reliability of the conclusions drawn.

Synthesizing Insights for a Resilient Cattle Health Ecosystem

In summary, the cattle health sector stands at a crossroads defined by technological innovation, regulatory evolution, and shifting economic paradigms. The intersection of advanced diagnostics, precision nutrition, and targeted therapeutics offers unprecedented potential to elevate animal welfare and operational efficiency. Yet, geopolitical developments and tariff policies present near-term challenges that require strategic agility and proactive risk management.

By leveraging granular segmentation insights and aligning with regional market dynamics, stakeholders can uncover high-impact growth areas and optimize resource allocation. Leading companies are already charting the path forward through integrated product portfolios, digital enablement, and manufacturing expansions, demonstrating that value creation extends far beyond core offerings.

Ultimately, success in this environment hinges on the ability to translate data-driven insights into cohesive strategies that balance innovation with resilience. As the sector continues to evolve, those who embrace collaborative partnerships, sustainable practices, and adaptive business models will emerge as the architects of a more robust and forward-looking cattle health ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Diagnostics
      • Laboratory Testing
      • Rapid Test Kits
    • Disinfectants & Sanitizers
    • Feed Additives
      • Enzymes
      • Prebiotics & Probiotics
      • Vitamins & Minerals
    • Pharmaceuticals
      • Anthelmintics
      • Anti-Inflammatories
      • Antibiotics
      • Hormones & Growth Promoters
    • Vaccines
      • Bacterial
      • Parasitic
      • Viral
  • Distribution Channel
    • Farm Supplies Outlets
    • Online Channels
    • Pharmacies
    • Veterinary Hospitals & Clinics
  • Cattle Type
    • Beef
    • Calves
    • Dairy
  • Disease Type
    • Bacterial Diseases
    • Metabolic Disorders
    • Parasitic Diseases
    • Reproductive Disorders
    • Respiratory Disorders
    • Viral Diseases
  • Route Of Administration
    • Inhalation
    • Injectable
    • Oral
    • Topical
  • Application
    • Growth Promotion
    • Nutritional Supplementation
    • Preventive
    • Reproductive Management
    • Therapeutic
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale SA
  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Neogen Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cattle Health Market, by Product Type
8.1. Introduction
8.2. Diagnostics
8.2.1. Laboratory Testing
8.2.2. Rapid Test Kits
8.3. Disinfectants & Sanitizers
8.4. Feed Additives
8.4.1. Enzymes
8.4.2. Prebiotics & Probiotics
8.4.3. Vitamins & Minerals
8.5. Pharmaceuticals
8.5.1. Anthelmintics
8.5.2. Anti-Inflammatories
8.5.3. Antibiotics
8.5.4. Hormones & Growth Promoters
8.6. Vaccines
8.6.1. Bacterial
8.6.2. Parasitic
8.6.3. Viral
9. Cattle Health Market, by Distribution Channel
9.1. Introduction
9.2. Farm Supplies Outlets
9.3. Online Channels
9.4. Pharmacies
9.5. Veterinary Hospitals & Clinics
10. Cattle Health Market, by Cattle Type
10.1. Introduction
10.2. Beef
10.3. Calves
10.4. Dairy
11. Cattle Health Market, by Disease Type
11.1. Introduction
11.2. Bacterial Diseases
11.3. Metabolic Disorders
11.4. Parasitic Diseases
11.5. Reproductive Disorders
11.6. Respiratory Disorders
11.7. Viral Diseases
12. Cattle Health Market, by Route of Administration
12.1. Introduction
12.2. Inhalation
12.3. Injectable
12.4. Oral
12.5. Topical
13. Cattle Health Market, by Application
13.1. Introduction
13.2. Growth Promotion
13.3. Nutritional Supplementation
13.4. Preventive
13.5. Reproductive Management
13.6. Therapeutic
14. Americas Cattle Health Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cattle Health Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cattle Health Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Zoetis Inc.
17.3.2. Merck & Co., Inc.
17.3.3. Boehringer Ingelheim International GmbH
17.3.4. Elanco Animal Health Incorporated
17.3.5. Ceva Santé Animale SA
17.3.6. Virbac SA
17.3.7. Dechra Pharmaceuticals PLC
17.3.8. Vetoquinol SA
17.3.9. Phibro Animal Health Corporation
17.3.10. Neogen Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CATTLE HEALTH MARKET MULTI-CURRENCY
FIGURE 2. CATTLE HEALTH MARKET MULTI-LANGUAGE
FIGURE 3. CATTLE HEALTH MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CATTLE HEALTH MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CATTLE HEALTH MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CATTLE HEALTH MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CATTLE HEALTH MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CATTLE HEALTH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CATTLE HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. CANADA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 79. CANADA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 80. CANADA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 81. CANADA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 82. CANADA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. CANADA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 85. CANADA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. CANADA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. MEXICO CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. GERMANY CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. GERMANY CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 140. GERMANY CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 141. GERMANY CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 142. GERMANY CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 143. GERMANY CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. GERMANY CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 145. GERMANY CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. GERMANY CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 153. FRANCE CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. FRANCE CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 155. FRANCE CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 156. FRANCE CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. FRANCE CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. ITALY CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. ITALY CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 170. ITALY CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 171. ITALY CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 172. ITALY CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 173. ITALY CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. ITALY CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 175. ITALY CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 176. ITALY CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. ITALY CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SPAIN CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SPAIN CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 180. SPAIN CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 181. SPAIN CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 182. SPAIN CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 183. SPAIN CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. SPAIN CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SPAIN CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. SPAIN CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. DENMARK CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. DENMARK CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 220. DENMARK CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 221. DENMARK CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 222. DENMARK CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 223. DENMARK CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. DENMARK CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 225. DENMARK CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 226. DENMARK CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. DENMARK CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. QATAR CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. QATAR CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 240. QATAR CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 241. QATAR CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 242. QATAR CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 243. QATAR CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. QATAR CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 245. QATAR CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 246. QATAR CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. QATAR CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. FINLAND CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. FINLAND CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 250. FINLAND CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 251. FINLAND CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 252. FINLAND CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 253. FINLAND CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. FINLAND CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 255. FINLAND CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 256. FINLAND CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. FINLAND CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. EGYPT CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. EGYPT CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 280. EGYPT CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 281. EGYPT CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 282. EGYPT CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 283. EGYPT CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. EGYPT CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 285. EGYPT CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 286. EGYPT CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. EGYPT CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. TURKEY CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. TURKEY CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 290. TURKEY CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 291. TURKEY CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 292. TURKEY CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 293. TURKEY CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. TURKEY CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 295. TURKEY CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 296. TURKEY CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. TURKEY CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 307. ISRAEL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. NORWAY CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. NORWAY CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 310. NORWAY CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 311. NORWAY CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 312. NORWAY CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 313. NORWAY CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. NORWAY CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 315. NORWAY CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 316. NORWAY CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 317. NORWAY CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. POLAND CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. POLAND CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 320. POLAND CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 321. POLAND CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 322. POLAND CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 323. POLAND CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. POLAND CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 325. POLAND CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 326. POLAND CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. POLAND CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 330. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 331. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 332. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 333. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 335. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 336. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 337. SWITZERLAND CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 340. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 342. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 345. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 346. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 347. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 348. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 349. CHINA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. CHINA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 351. CHINA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 352. CHINA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 353. CHINA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 354. CHINA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 355. CHINA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2030 (USD MILLION)
TABLE 356. CHINA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 357. CHINA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 358. CHINA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 359. INDIA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 360. INDIA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 361. INDIA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 362. IN

Companies Mentioned

The companies profiled in this Cattle Health market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale SA
  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Neogen Corporation

Methodology

Loading
LOADING...

Table Information